Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 2 1

Status

Completed 8Unknown 5Withdrawn 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Classical hematology 5Breast 3Gynecologic 2

Conditions

Breast Neoplasms 1476Neoplasms 999Colorectal Neoplasms 830Carcinoma, Non-Small-Cell Lung 724Carcinoma, Hepatocellular 683Stomach Neoplasms 647Lung Neoplasms 584Prostatic Neoplasms 543Pancreatic Neoplasms 456Rectal Neoplasms 338Uterine Cervical Neoplasms 303Colonic Neoplasms 295Neoplasm Metastasis 292Ovarian Neoplasms 285Esophageal Neoplasms 279Recurrence 278Leukemia, Myeloid, Acute 253Head and Neck Neoplasms 241Multiple Myeloma 232Brain Neoplasms 204Polycystic Ovary Syndrome 200Nasopharyngeal Carcinoma 198Melanoma 198Precursor Cell Lymphoblastic Leukemia-Lymphoma 195Urinary Bladder Neoplasms 193Lymphoma 178Liver Neoplasms 178Endometrial Neoplasms 159Motor Activity 147Lymphoma, Large B-Cell, Diffuse 141

Interventions

Trabectedin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Unknown × OTHER × Fanconi Anemia, Complementation Group D1 × Clear all
NCT02959398 2017-11-24

ETOLE

Assistance Publique - Hôpitaux de Paris

Phase NA Unknown
2,000 enrolled
BreastClassical hematology

Fanconi Anemia, Complementation Group D1, Breast Neoplasms

NCT00413491 2014-05-20

MR BRCA

Danish Breast Cancer Cooperative Group

Phase 4 Unknown
300 enrolled
BreastClassical hematology

Fanconi Anemia, Complementation Group D1, Breast Neoplasms

NCT01772979 2013-01-21

MITO15

Catholic University of the Sacred Heart

Phase 2 Unknown
100 enrolled
Classical hematologyGynecologic

Fanconi Anemia, Complementation Group D1, Ovarian Neoplasms

NCT00509509 2012-05-24

High Risk Breast Cancer Screening Program

Organisation for Oncology and Translational Research

Unknown
BreastClassical hematology

Breast Cancer, Familial, Fanconi Anemia, Complementation Group D1, Breast Neoplasms

NCT00155896 2005-09-12

Establishing the Incidences of BRCA1 and BRCA2 Mutation by Combining DHPLC and Direct Sequencing in Ovarian Cancer

National Taiwan University Hospital

Unknown
100 enrolled
Classical hematologyGynecologic

Fanconi Anemia, Complementation Group D1, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡